2017 H1 M&A review - China pharmaceuticals and medical devices sectors

Aug 2017

PwC recently launched 2017 H1 M&A review - China pharmaceuticals and medical devices sectors with highlights and cases occurred from January to June this year. Compared with 2016, the M&A market of China pharmaceuticals and medical devices sectors dropped both in value and volume of deals, while VC investors were still active in terms of deal volume.
 

 Download 2017 H1 M&A review

China pharmaceuticals sector China medical devices sector

Contact us

Xun Tang
China Central Transaction Services Leader
Tel: +[86] (21) 2323 3396
Email

Follow us